Sodium Tauroursodeoxycholate (TUDC)

Sodium Tauroursodeoxycholate (TUDC) is a water soluble bile salt, used for the treatment of gallstones and liver cirrhosis.

Sodium Tauroursodeoxycholate (TUDC) Chemical Structure

Sodium Tauroursodeoxycholate (TUDC) Chemical Structure

CAS No. 35807-85-3

Purity & Quality Control

Sodium Tauroursodeoxycholate (TUDC) Related Products

Biological Activity

Description Sodium Tauroursodeoxycholate (TUDC) is a water soluble bile salt, used for the treatment of gallstones and liver cirrhosis.
In vitro
In vitro In vitro, Tauroursodeoxycholate shows protective and reversing effects on 17βEG-induced impairment of the cVA-of-CLF. [1] In Mz-ChA-1 cholangiocarcinoma cells, Tauroursodeoxycholate inhibits cell growth via Ca2+-, PKC-, and MAPK-dependent pathways. [3] In isolated rat hepatocytes, Tauroursodeoxycholate inhibits bile acid-Induced Apoptosis via a β1-integrin-mediated formation of cAMP. [4]
Cell Research Cell lines Mz-ChA-1 cells
Concentrations ~200 μM
Incubation Time 96 h
Method After trypsinization, Mz-ChA-1 cells are suspended in CCM at 5 × 104 cells/mL, and 200 μL of the cell suspension are seeded into flat-bottomed 96-well plates. After an initial incubation step of 4 h at 37°C in a 5% CO2 incubator, the cells are incubated at 37°C with TUDCA (0.2–200 μM). After incubation for 24–96 h, [3H]thymidine is put into each well at 5.0 μCi/mL and incubated for additional 4 h. [3H]thymidine incorporation is measured by a scintillation counter. At the end of each incubation period, cell viability is evaluated by trypan blue exclusion.
In Vivo
In vivo In phalloidin-induced cholestasis rats, Tauroursodeoxycholate (360 μmol/kg, i.v.) significantly suppresses the decrease in bile flow and increases in serum alkaline phosphatase, leucine aminopeptidase and glutamic pyruvic transaminase activities, cholesterol, phospholipid and bile acid concentrations. [2]
Animal Research Animal Models Phalloidin-induced cholestasis rats
Dosages 360 μmol/kg
Administration i.v.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05753852 Recruiting
Amyotrophic Lateral Sclerosis
Humanitas Mirasole SpA|University of Ulm|University of Sheffield|University Hospital Tours|KU Leuven|UMC Utrecht|University of Dublin Trinity College|Bruschettini S.r.l.|Istituto Superiore di Sanità|Motor Neurone Disease Association
October 25 2021 Phase 3
NCT04114292 Unknown status
Ulcerative Colitis
Washington University School of Medicine|Crohn''s and Colitis Foundation
January 17 2019 Phase 1

Chemical Information & Solubility

Molecular Weight 521.69 Formula

C26H44NNaO6S

CAS No. 35807-85-3 SDF Download Sodium Tauroursodeoxycholate (TUDC) SDF
Smiles CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C.[Na+]
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 100 mg/mL ( (191.68 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 100 mg/mL

Ethanol : 46 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
What’s the difference between TUDC (S7896) and TUDCA (S3654)?

Answer:
Our product TUDC is the sodium salt of TUDCA.

Tags: buy Sodium Tauroursodeoxycholate (TUDC) | Sodium Tauroursodeoxycholate (TUDC) ic50 | Sodium Tauroursodeoxycholate (TUDC) price | Sodium Tauroursodeoxycholate (TUDC) cost | Sodium Tauroursodeoxycholate (TUDC) solubility dmso | Sodium Tauroursodeoxycholate (TUDC) purchase | Sodium Tauroursodeoxycholate (TUDC) manufacturer | Sodium Tauroursodeoxycholate (TUDC) research buy | Sodium Tauroursodeoxycholate (TUDC) order | Sodium Tauroursodeoxycholate (TUDC) mouse | Sodium Tauroursodeoxycholate (TUDC) chemical structure | Sodium Tauroursodeoxycholate (TUDC) mw | Sodium Tauroursodeoxycholate (TUDC) molecular weight | Sodium Tauroursodeoxycholate (TUDC) datasheet | Sodium Tauroursodeoxycholate (TUDC) supplier | Sodium Tauroursodeoxycholate (TUDC) in vitro | Sodium Tauroursodeoxycholate (TUDC) cell line | Sodium Tauroursodeoxycholate (TUDC) concentration | Sodium Tauroursodeoxycholate (TUDC) nmr